Valganciclovir for CMV Prophylaxis After PTCy-Based Allogeneic Hematopoietic Cell Transplantation.
Saved in:
| Title: | Valganciclovir for CMV Prophylaxis After PTCy-Based Allogeneic Hematopoietic Cell Transplantation. |
|---|---|
| Authors: | Tawfik N; Clinical Haematology, Alfred Health, Melbourne, Victoria, Australia., Scott AP; Haematology and Bone Marrow Transplantation, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia., Cashion C; Blood Transplant and Cell Therapies Program, Westmead Hospital, Sydney, and Faculty Medicine and Health, University of Sydney, New South Wales, Australia., Schwarer J; Clinical Haematology, Alfred Health, Melbourne, Victoria, Australia., Gleeson MJ; Haematology and Bone Marrow Transplantation, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia., Tan JL; Clinical Haematology, Alfred Health, Melbourne, Victoria, Australia., Ashby M; Clinical Haematology, Alfred Health, Melbourne, Victoria, Australia., Coutsouvelis J; Pharmacy Department, Alfred Health, Melbourne, Victoria, Australia; Centre for Medicine Use and Safety, Monash University, Parkville, Victoria, Australia., Fernando S; Pharmacy Department, Alfred Health, Melbourne, Victoria, Australia., Do L; Blood Transplant and Cell Therapies Program, Westmead Hospital, Sydney, and Faculty Medicine and Health, University of Sydney, New South Wales, Australia., Cirone B; Clinical Haematology, Alfred Health, Melbourne, Victoria, Australia., Wong SM; Clinical Haematology, Alfred Health, Melbourne, Victoria, Australia., Patil SS; Clinical Haematology, Alfred Health, Melbourne, Victoria, Australia., Inam S; Clinical Haematology, Alfred Health, Melbourne, Victoria, Australia., Gardiner BJ; Department of Infectious Diseases, Alfred Health and School of Translational Medicine, Monash University, Melbourne, Victoria, Australia., Fleming SA; Clinical Haematology, Alfred Health, Melbourne, Victoria, Australia., Grigg AP; Department of Haematology, Austin Health & University of Melbourne, Melbourne, Victoria, Australia., Spencer A; Clinical Haematology, Alfred Health, Melbourne, Victoria, Australia; Australian Centre for Blood Diseases, School of Translational Medicine, Monash University, Melbourne, Victoria, Australia., Gottlieb DJ; Blood Transplant and Cell Therapies Program, Westmead Hospital, Sydney, and Faculty Medicine and Health, University of Sydney, New South Wales, Australia., Morrissey CO; Department of Infectious Diseases, Alfred Health and School of Translational Medicine, Monash University, Melbourne, Victoria, Australia; Centre to Impact AMR, Monash University, Melbourne, Victoria, Australia., Curtis DJ; Clinical Haematology, Alfred Health, Melbourne, Victoria, Australia; Australian Centre for Blood Diseases, School of Translational Medicine, Monash University, Melbourne, Victoria, Australia. Electronic address: david.curtis@monash.edu. |
| Source: | Transplantation and cellular therapy [Transplant Cell Ther] 2026 Jun 06. Date of Electronic Publication: 2026 Jun 06. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101774629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-6367 (Electronic) Linking ISSN: 26666367 NLM ISO Abbreviation: Transplant Cell Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
